The concept of saline nasal irrigation, or bathing the nasal passages with a saltwater solution, is thought to have been ...
The ReBoost Nasal Spray may contain mold and microbial contamination, while the ClearLife Allergy Nasal Spray may be linked to the same bacteria.
European decision on approval is expected by Q1 2027If approved, etripamil nasal spray is expected to offer patients a safe and effective ...
Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.
AVAILABLE OPTIONS TO STAY ON TRACK. THE FDA HAS EXPANDED ITS RECALL OF A NASAL SPRAY PRODUCED HERE IN NEW MEXICO. THE MEDINATURA PRODUCTS CONTAINED DANGEROUS LEVELS OF YEAST, MOLD AND MICROBIAL ...
Tiziana's foralumab continues to be safe and well-tolerated, with no drug-related serious side effects after long-term use, ...
In a season marked by early surges and a dominant drifted strain, experts stress layered protection. For the millions vaccinated and not vaccinated this year, innovations like Polyrizon's PL-16 has ...
The U.S. Food and Drug Administration is warning consumers about a nationwide recall involving nasal sprays that could lead to life-threatening illness. MediNatura New Mexico Inc. is recalling one lot ...
The U.S. Food and Drug Administration is recalling ClearLife Allergy Nasal Spray after it says microbial contamination was found inside. Milwaukee judge found guilty of obstruction after allegedly ...
The FDA has expanded its nationwide recall of Reboost nasal spray to now include Clear-Life Allergy nasal spray. Suspected Brown University gunman found dead The Trump admin is closing a critical ...
A popular nasal spray sold at retailers nationwide is being recalled because it was found to contain mold and microbial contamination, with customers urged to "immediately" discontinue using the ...
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly resolve episodes of PSVT and restore sinus rhythm FDA approval in PSVT ...